The Emmott lab was awarded a Springboard award from the Academy of Medical Sciences in support of the labs single-cell proteomics work titled: ‘Exploiting and advancing single-cell proteomics to identify novel pathways to disrupt RNA virus infection.’
A PDRA position for this work will be advertised in the near future, looking for a postdoctoral researcher with proteomics experience on orbitrap mass specs, keen to develop and apply single-cell proteomic methods on top end instruments including a brand new Thermo Exploris 480 with FAIMS and Bruker timsTOF pro.
The AMS Springboard Awards are generously supported by the British Heart Foundation, Diabetes UK, the Global Challenges Research Fund, the Government Department for Business, Energy and Industrial Strategy and the Wellcome Trust.
Comments are closed, but trackbacks and pingbacks are open.